Maruho Report 2023261.Maruho’s Meaning of Existenceknow-how by being involved in the manufacturing methods and prototyping processes of our outsourcing partners. In order to establish a stable supply system, we have also started work to increase the production capacity of Roman Industries Co. Ltd..We will support our management base by appropriately controlling the supply and procurement risks of products and raw materials, and by always providing a stable supply of products. In addition, we will independently improve the containers and packaging of products to flexibly respond to needs and utilize new technologies. As part of these efforts, we plan to establish a production strategy for each product based on its long-term development and achieve highly efficient production.2.Value Creation Prospects3.Strategy for Value Creation4.Foundation for Sustainable Growth5.Financial/ Company InformationHikone PlantNagahama PlantAssessment of the fiscal year ended September 2023Completed large-scale renewal of main plant and made progress with integrated operations of the four plantsIn our production activities, we continue to make capital investments to build a robust and flexible production system. In the fiscal year ended September 2023, we completed the renewal of the filling and packaging building of the Hikone Plant. Over the course of about three years, we completed this work as planned while continuing the production of existing products. In addition, we established a system and mechanism for visualizing spare parts at all plants for the integrated operation of the four plants. We are also steadily reducing quality risks through automation and workload reduction measures using new and digital technologies.In the manufacturing of APIs, we have accumulated Plan for the fiscal year ending September 2024 and beyondExpand production system and acquire technologies for producing unique productsIn order to achieve the Fifth Medium-Term Plan, we aim to pursue a production strategy unique to Maruho that leverages our thorough knowledge of the external environment and our own strengths. We will also acquire advanced production technology and production management know-how.Tateyama Pharmaceutical Factory Co., Ltd.Roman Industries Co., Ltd.With the aim of realizing its Mission, Maruho conducts all business activities, including R&D, manufacturing, and sales, in full compliance with all relevant laws and regulations, as well as the general spirit of international standards, both in Japan and overseas. We actively and continuously engage in the R&D of innovative pharmaceuticals that contribute to the advancement of medicine, and provide a stable supply of pharmaceuticals with excellent efficacy, safety, and quality. To ensure the proper use of pharmaceuticals, we provide accurate, scientifically based information of Japan and international markets on efficacy, safety, and quality, and promptly collect, evaluate, and communicate information post manufacturing and marketing.We have reaffirmed our reliability assurance activities as a strength that needs to be further deepened and have positioned them as one of the priority themes of our operations in the Fifth Medium-Term Plan. We aim to ensure that our reliability assurance culture becomes a code of conduct for all employees and becomes established as a brand power of Maruho. We will build a culture where all employees understand the importantance of reliability, how it contributes to patients, and can discuss why reliability must be ensured.In the fiscal year ending September 2024, we plan to clearly document our companywide policy and communicate it both internally and externally as Maruho's commitment. In businesses other than pharmaceuticals, we aim to establish a robust reliability assurance system by accumulating practical experience in reliability assurance at an appropriate level and scale. In order to steadily advance each of these measures, we plan to systematically develop and acquire human resources.Maruho is deeply committed to continuing to reliably deliver high-quality products to patients. Based on this commitment, we aim to develop human resources with a broad perspective who can enhance their expertise in production technology and who can give back to society by promoting a wide range of collaboration both inside and outside the company and promoting environmental considerations.Masahiro TakedaCorporate Strategy, CMC Research & ProductionFocusing on fostering a culture ofreliability assuranceExpertise in production technologies and broad perspectives
元のページ ../index.html#27